Growth Metrics

Dna X (SONM) Non-Current Receivables (2022 - 2023)

Dna X filings provide 2 years of Non-Current Receivables readings, the most recent being $7.9 million for Q3 2023.

  • On a quarterly basis, Non-Current Receivables changed N/A to $7.9 million in Q3 2023 year-over-year; TTM through Sep 2023 was $7.9 million, a N/A change, with the full-year FY2022 number at $6.8 million, changed N/A from a year prior.
  • Non-Current Receivables hit $7.9 million in Q3 2023 for Dna X, up from $7.0 million in the prior quarter.
  • In the past five years, Non-Current Receivables ranged from a high of $7.9 million in Q3 2023 to a low of $6.8 million in Q4 2022.